enGene Holdings Inc. (ENGN)
NCM · Common · CUSIP 29286M105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ENGN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29286M105
IPO
12/10/2021 · $10.00/unit
Previous Symbol
FRBN (changed 11/1/2023)
Previous Name
Forbion European Acquisition Corp
Business: enGene Holdings Inc. is a late-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs.

Company Contact

CEO
Ron Cooper
CFO
Ryan Daws
Headquarters
4868 Rue Levy, Suite 220, Saint-Laurent, QC, Canada
Phone
514-332-4888
Investor Relations
Investors@enGene.com
SEC EDGAR Filings
View filings »